Axovant Announces Data to be Presented at the Annual Congress of the European Society of Gene and Cell Therapy
Axon Enterprise, Inc. (AXON)
Last axon enterprise, inc. earnings: 2/7 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.axovant.com/investors/sec-filings
Company Research
Source: GlobeNewswire
BASEL, Switzerland, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ:AXON), a gene therapy company developing innovative treatments for debilitating neurologic and neuromuscular diseases, today announced upcoming presentations regarding its investigational gene therapy programs, AXO-Lenti-PD and AXO-AAV-OPMD, at the Annual Congress of the European Society of Gene and Cell Therapy (ESGCT) being held in Lausanne, Switzerland from October 16th to 19th, 2018. Prosavin®, a dopamine gene therapy for advanced Parkinson’s disease: 5 years phase I/II clinical update Date: October 17, 2018 Time: 13:10-15:10 CEST Location: Garden Floor, Poster session 1Poster Number: P201 AXO-Lenti-PD for Parkinson’s disease: endogenous dopamine production by intraputamenal three-gene transfer Presented by: Fraser Wright, Chief Technology Officer of Axovant During the lunch workshop on the use of lentiviral vectors for in vivo gene therapyDate: October 18, 2018 Time: 13:15-14:15 CEST Location:
Show less
Read more
Impact Snapshot
Event Time:
AXON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXON alerts
High impacting Axon Enterprise, Inc. news events
Weekly update
A roundup of the hottest topics
AXON
News
- Global Swarm Intelligence Market Analysis Report 2024: Ant Colony Optimization Leads Market with 45.0% Share in 2023 - Forecast to 2030 for the $300+ Million Industry [Yahoo! Finance]Yahoo! Finance
- 25 US States with the Highest Number of Police Officers Per Capita [Yahoo! Finance]Yahoo! Finance
- Beyond The TASER: How Axon Is Revolutionizing Public Safety (And Your Portfolio) [Seeking Alpha]Seeking Alpha
- 20 Largest Police Departments in the US [Yahoo! Finance]Yahoo! Finance
- 20 Universities with the Largest Police Departments in the US [Yahoo! Finance]Yahoo! Finance
AXON
Earnings
- 2/27/24 - Beat
AXON
Sec Filings
- 3/18/24 - Form PRE
- 3/18/24 - Form 4
- 3/18/24 - Form 4
- AXON's page on the SEC website